Author: F. Sharp,W. P. Mason,W. Creasman
Publisher: Chapman & Hall; 1st edition (January 1, 1993)
Category: Medicine & Health Sciences
Size Fb2: 1584 kb
Size ePub: 1141 kb
Size Djvu: 1133 kb
Other formats: doc lit mobi lrf
In Ovarian Cancer 2: Biology, Diagnosis and, W. Management, (eds F. Sharp, . Mason and W. Creasman), Chapman & Hall, London, pp. 127–45.
In Ovarian Cancer 2: Biology, Diagnosis and, W. Berchuck, . Marks, . Jr. (1992) Expression of the epidermal growth factor receptor, HER-2/neu, and p53 in ovarian cancer. In Ovarian Cancer 2: Biology, Diagnosis and Management, (eds F. 53–9.
Ovarian Cancer 2 book. Goodreads helps you keep track of books you want to read. Start by marking Ovarian Cancer 2: Biology, Diagnosis and Management as Want to Read: Want to Read savin. ant to Read. See a Problem? We’d love your help.
This article outlines the diagnosis and management of ovarian cancer. Epithelial ovarian cancer presents most often as late stage disease due to a lack of effective screening tests and vagueness of symptoms. This article outlines the diagnosis and management of ovarian cancer. Women with suspected ovarian cancer are best managed in a gynaecological treatment unit offering multidisciplinary care. Surgery is usually needed both to make a diagnosis and for definitive treatment and referral to a specialty trained gynaecological oncologist is appropriate.
The early diagnosis of ovarian cancer is a matter of chance and not a. .New York: Igaku Shoin.
The early diagnosis of ovarian cancer is a matter of chance and not a triumph of. scientific approach. Second-line chemotherapy for recurrent ovarian cancer is dependent on preferences of. both the patient and physician. Retreatment with platinum therapy appears to offer. Ovarian Carcinoma: Etiology, Diagnosis, and Treatment. New York: Springer Verlag.
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books.
Ovarian Cancer 2: Biology, Diagnosis and Management (v. 2. Coauthors & Alternates. Learn More at LibraryThing. 2). by F. Sharp, W. P. Mason. ISBN 9780412451904 (978-0-412-45190-4) Hardcover, Chapman & Hall, 1993. W. Mason at LibraryThing.
Chemoimmunotherapy with a combination of low-dose cisplatin and recombinant interleukin 2. In: Sharp F, Masen WP, Creasman W (eds) Ovarian cancer 2. Biology, diagnosis and management. M Bernsen, HFJ Dullens, W Den Otter, APM Heintz.
Surgical Procedures for Ovarian Cancer A. Initial surgical procedure for diagnosis and staging: 1. Objective is to. Objective is to define stage and to remove as much of the tumor as possible. NIH consensus recommendations regarding management of ovarian cancer A. Women with masses having a significant risk of malignancy should be given the opportunity to have surgery performed by a gynecologic oncologist B. Aggressive cytoreductive surgery as primary management of ovarian cancer will improve chances for long term survival C. Fully staged FIGO IA-1 and IB-1 ovarian cancers do not require postoperative.
The greatly elevated cancer risk in indivi-duals with familial cancer .
The greatly elevated cancer risk in indivi-duals with familial cancer syndromes increasingly raises the prospect of preven-tive surgery, . mastectomy in carriers of BRCA1/2 mutations and colectomy in patients with familial adenomatosis coli. Surgical management is underpinned by recognition of the whole patient, and not merely focused on tumour excision.